Investigation of a 3 oz Water Protocol on Patients With Tracheostomies

Sponsor
Icahn School of Medicine at Mount Sinai (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06120790
Collaborator
(none)
80
1
13
6.1

Study Details

Study Description

Brief Summary

Examining the validity of a novel 3 oz protocol in patients with tracheostomies as compared to the gold standard of instrumental swallow assessments (Flexible Endoscopic Evaluation of the Swallow or Modified Barium Swallow Study).

Condition or Disease Intervention/Treatment Phase
  • Other: 3 Oz water screen

Detailed Description

The purpose of this research study is to determine if a 3 oz water screening protocol is an effective screen for patients with openings in their airways (i.e. tracheostomies). This procedure is already in use for many different populations and is particularly useful for clinicians who want to understand who is at risk for having food or liquid enter the lungs while eating or drinking (i.e. aspiration).

Study Design

Study Type:
Observational
Anticipated Enrollment :
80 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Investigation of a 3 oz Water Protocol on Patients With Tracheostomies
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Patients with Tracheostomies

Patients with openings in their airways (i.e. tracheostomies)

Other: 3 Oz water screen
Patient will consume 3 oz of water continuously without stopping and then will be monitored for one minute post completion. Patient will complete this twice in the same session.

Outcome Measures

Primary Outcome Measures

  1. Swallow screen [End of participation study within 7 days of enrollment]

    Swallow screen measured as pass/fail for presence or absence of aspiration

  2. Penetration Aspiration Scale Score [End of participation study within 7 days of enrollment]

    The penetration aspiration scale (PAS) is a validated measure used by trained blinded clinicians to assign ratings of safety to swallowing bolus trials. The PAS is an 8-point, equal-appearing interval scale (8 being best; 1 being worst) to describe penetration and aspiration events. Scores are determined primarily by the depth to which material passes in the airway and by whether or not material entering the airway is expelled. Higher scores indicate better health outcomes.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Has a tracheostomy

  • Able to remain alert for testing

  • Not on a modified diet for pre-existing dysphagia

  • No head of bed restrictions

  • Not NPO by physician for any reason other than possible dysphagia

  • At least 18 years old

Exclusion Criteria:
  • Does not have a tracheostomy

  • Unable to remain alert for testing

  • On a modified diet due to pre-existing dysphagia

  • Head of bed restrictions for greater than or equal to 30 degrees

  • NPO by physician for reasons other than possible dysphagia

  • Less than 18 years old

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mount Sinai Hospital New York New York United States 10029

Sponsors and Collaborators

  • Icahn School of Medicine at Mount Sinai

Investigators

  • Principal Investigator: Miguel Escalon, Icahn School of Medicine at Mount Sinai

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Miguel Escalon, Associate Professor, Icahn School of Medicine at Mount Sinai
ClinicalTrials.gov Identifier:
NCT06120790
Other Study ID Numbers:
  • STUDY-23-00005
First Posted:
Nov 7, 2023
Last Update Posted:
Nov 7, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No

Study Results

No Results Posted as of Nov 7, 2023